Volume 22 Issue 12
Dec.  2024
Turn off MathJax
Article Contents
Article Navigation >  Chinese Journal of General Practice  > 2024  >  22(12): 2062-2065
DU Wei, MA Yingying, FU Leming, LI Jun. Analysis of the efficacy and safety of Pralofen combined with Emadine in the treatment of allergic conjunctivitis[J]. Chinese Journal of General Practice, 2024, 22(12): 2062-2065. doi: 10.16766/j.cnki.issn.1674-4152.003798
Citation: DU Wei, MA Yingying, FU Leming, LI Jun. Analysis of the efficacy and safety of Pralofen combined with Emadine in the treatment of allergic conjunctivitis[J]. Chinese Journal of General Practice, 2024, 22(12): 2062-2065. doi: 10.16766/j.cnki.issn.1674-4152.003798
shu

Analysis of the efficacy and safety of Pralofen combined with Emadine in the treatment of allergic conjunctivitis

doi: 10.16766/j.cnki.issn.1674-4152.003798
  • 1.

    Department of Ophthalmology, Shaoxing Maternal and Child Health Hospital, Shaoxing, Zhejiang 312000, China

Funds:

 2020RC151

  • Received Date: 2024-08-22
    Available Online: 2025-01-20
    Abstract
  •   Objective  Allergic conjunctivitis (AC) is a common ocular surface disease. Although single-drug treatment can alleviate symptoms, the efficacy is limited, and the recurrence rate is high. Therefore, exploring combination therapy strategies to optimize treatment plans is of great significance. The aim of this study is to investigate the efficacy and safety of Pralofen combined with Emadine in the treatment of AC, providing, reference for clinical treatment planning.  Methods  A total of 124 patients with AC admitted to the ophthalmology department of our hospital from October 2023 to June 2024 were randomly divided into Group A and Group B. Group A, consisting of 62 patients, was treated with Pralofen, while Group B, consisting of 62 patients, was treated with Pralofen combined with Emadine. The improvement of symptoms, tear film stability, tear index levels, inflammatory factor levels, clinical efficacy, and adverse reactions were observed in both groups.  Results  The scores of photophobia, tearing, eye itching, and eye secretions in group B were lower than those in group A after treatment (P < 0.05). The BUT of group B after treatment was longer than that of group A (P < 0.05), and the CFS score was lower than that of group A (P < 0.05). The ECP, HA, and LTB4 levels in group B were lower than those in group A after treatment (P < 0.05). The levels of IL-6, TNF-α, and hs-CRP in group B were lower than those in group A after treatment (P < 0.05). The total effective rate of Group B was 91.94% (57/62), which was higher than that of Group A [75.81% (47/62)], with P < 0.05. The incidence of adverse reactions in Group B was 8.06% (5/62), which was slightly lower than that of Group A [12.90% (8/62)], with P>0.05.  Conclusion  Pralofen combined with Emadine has a good effect on the treatment of AC, which can effectively alleviate patient symptoms, improve tear film stability, improve tear index levels and inflammatory factor levels, and has fewer adverse reactions. It is effective and safe and is worth promoting.

     

    • FullText(HTML)
  • loading
    • References(22)
  • [1]
    LEONARDI A, QUINTIERI L, PRESA I J, et al. Allergic conjunctivitis management: update on ophthalmic solutions[J]. Curr Allergy Asthma Rep, 2024, 24(7): 347-360. doi: 10.1007/s11882-024-01150-0
    [2]
    LIU K C, CAI Y J, SONG K, et al. Clarifying the effect of gut microbiota on allergic conjunctivitis risk is instrumental for predictive, preventive, and personalized medicine: a Mendelian randomization analysis[J]. EPMA J, 2023, 14(2): 235-248. doi: 10.1007/s13167-023-00321-9
    [3]
    李晓庄, 殷文静, 范其佩, 等. 奥洛他定联合普拉洛芬治疗过敏性结膜炎疗效和安全性的meta分析[J]. 国际眼科杂志, 2022, 22(11): 1844-1850.

    LI X Z, YIN W J, FAN Q P, et al. Meta analysis of the efficacy and safety of Olopathidine combined with Pralofen in the treatment of allergic conjunctivitis[J]. International Journal of Ophthalmology, 2022, 22(11): 1844-1850.
    [4]
    李昆, 李鹏, 刘擎. 富马酸依美斯汀联合氟米龙滴眼液治疗过敏性结膜炎[J]. 国际眼科杂志, 2024, 24(6): 1000-1004.

    LI K, LI P, LIU Q. Treatment of allergic conjunctivitis with Emestine fumarate combined with Flumerone eye drops[J]. International Journal of Ophthalmology, 2024, 24(6): 1000-1004.
    [5]
    中华医学会眼科学分会角膜病学组. 我国过敏性结膜炎诊断和治疗专家共识(2018年)[J]. 中华眼科杂志, 2018, 54(6): 409-414.

    Corneal Disease Group of the Ophthalmology Branch of the Chinese Medical Association. Expert consensus on diagnosis and treatment of allergic conjunctivitis in China (2018)[J]. Chinese Journal of Ophthalmology, 2018, 54(6): 409-414.
    [6]
    黄海东, 袁志敏, 邢杰, 等. 色甘酸钠联合双氯芬酸钠滴眼液治疗过敏性结膜炎的疗效[J]. 中国医师杂志, 2022, 24(8): 1215-1219.

    HUANG H D, YUAN Z M, XING J, et al. Efficacy of sodium Selenate combined with Diclofenac sodium eye drops in the treatment of allergic conjunctivitis[J]. Chinese Journal of Physicians, 2022, 24(8): 1215-1219.
    [7]
    徐艳, 林智, 吴育芝. 奥洛他定滴眼液联合普拉洛芬滴眼液治疗过敏性结膜炎患者的临床研究[J]. 中国临床药理学杂志, 2023, 39(3): 345-348.

    XU Y, LIN Z, WU Y Z. Clinical study on the treatment of allergic conjunctivitis patients with Olotadine eye drops combined with Pralofen eye drops[J]. Chinese Journal of Clinical Pharmacology, 2023, 39(3): 345-348.
    [8]
    许行艳, 潘可生. 曲安奈德联合氟米龙滴眼液治疗过敏性结膜炎的临床研究[J]. 现代药物与临床, 2023, 38(7): 1742-1745.

    XU X Y, PAN K S. Clinical study on the treatment of allergic conjunctivitis with Triamcinolone acetonide combined with Flumeron eye drops[J]. Modern Medicine and Clinical, 2023, 38(7): 1742-1745.
    [9]
    KALANGARA J P, VANIJCHAROENKARN K, CHISOLM S, et al. Neuropathic pain and itch: mechanisms in allergic conjunctivitis[J]. Curr Opin Allergy Clin Immunol, 2022, 22(5): 298-303.
    [10]
    CRETICOS P S, GUNAYDIN F E, NOLTE H, et al. Allergen immunotherapy: the evidence supporting the efficacy and safety of subcutaneous immunotherapy and sublingual forms of immunotherapy for allergic rhinitis/conjunctivitis and asthma[J]. J Allergy Clin Immunol Pract, 2024, 12(6): 1415-1427.
    [11]
    DOGAN C U, TUZER C, TURKER I C, et al. Topical cyclosporine versus allergen specific immunotherapy in perennial allergic conjunctivitis[J]. Int Ophthalmol, 2023, 43(7): 2161-2169.
    [12]
    MONTERO-IRUZUBIETA J, SANCHEZ HERNANDEZ M C, DAVILA I, et al. The importance of preventing and managing tear dysfunction syndrome in allergic conjunctivitis and how to tackle this problem[J]. J Investig Allergol Clin Immunol, 2023, 33(6): 439-445.
    [13]
    SALONEN J, REMITZ A, SALONEN J, et al. Allergic conjunctivitis: a risk factor for recurrent herpes simplex virus infections in patients with atopic dermatitis[J]. Eur J Dermatol, 2022, 32(5): 607-614.
    [14]
    TANAKA H, TATSUKAWA Y, YOSHITOMI K, et al. Effects of antihistamine-releasing contact lenses on severe allergic conjunctivitis[J]. Ocul Immunol Inflamm, 2023, 31(8): 1674-1676.
    [15]
    GENG Z, GAO L, LI C Y, et al. The necessity of pretreatment with 0.1% pranoprofen for femtosecond-assisted cataract surgery: a single-center, randomized controlled trial[J]. Adv Ophthalmol Pract Res, 2023, 20(4): 153-158.
    [16]
    LU H W, GUAN Y Q, SU Y D, et al. Effect of sodium hyaluronate eye drops combined with tobramycin, dexamethasone and pranoprofen eye drops in the treatment of dry eye after phacoemulsification[J]. Indian J Ophthalmol, 2022, 70(12): 4319-4324.
    [17]
    CHEN T, ROELOFS K A, ROOTMAN D B. Allergic conjunctivitis and contact dermatitis following silicone tube intubation[J]. Can J Ophthalmol, 2023, 58(1): 36-38.
    [18]
    DOU X Y, ZHANG W. Topical ketotifen treatment for allergic conjunctivitis: a systematic review and meta-analysis[J]. Int J Ophthalmol, 2023, 16(2): 286-292.
    [19]
    LI S Y, ZHONG S Q. Comparison of olopatadine with ketotifen for allergic conjunctivitis: a meta-analysis study[J]. Postepy Dermatol Alergol, 2023, 40(2): 326-330.
    [20]
    TAJBAKHSH Z, GOLEBIOWSKI B, STAPLETON F, et al. Increased dendritic cell density and altered morphology in allergic conjunctivitis[J]. Eye (Lond), 2023, 37(14): 2896-2904.
    [21]
    畅立斌, 蔡小会. 色素失禁症相关性视网膜病变眼前房水多因子分析[J]. 中国临床医生杂志, 2021, 49(11): 1375-1378.

    CHANG L B, CAI X H. Multifactor analysis of anterior aqueous humor in retinal lesions associated with pigment incontinence[J]. Chinese Journal of Clinical Physicians, 2021, 49(11): 1375-1378.
    [22]
    郝泽林, 吴建跃, 滕振飞, 等. 急性脑梗死患者血清学指标与神经功能缺损和脑梗死体积及颈动脉斑块性质的相关性研究[J]. 中华全科医学, 2020, 18(11): 1803-1806. doi: 10.16766/j.cnki.issn.1674-4152.001623

    HAO Z L, WU J Y, TENG Z F, et al. Study on the correlation between serological indicators and neurological deficits, cerebral infarction volume, and carotid plaque properties in patients with acute cerebral infarction[J]. Chinese Journal of General Practice, 2020, 18(11): 1803-1806. doi: 10.16766/j.cnki.issn.1674-4152.001623
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(4)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (189) PDF downloads(6) Cited by()
    Proportional views
    Related

    Address：No. 287, Changhuai Road, Bengbu, Anhui Province, 233004, P.R.ChinaphoneNo：0552-3066635； 0552-3051890Email：zhqkyx@163.com

    Copyright © Chinese Journal of General Practice皖ICP备2020018345号-2

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return